title: The timing of radium-223 therapy in castration-resistant prostate cancer.
authors.affiliation: Tulane Cancer Center, Departments of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana.
authors.forename: Oliver
authors.initials: O
authors.lastname: Sartor
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000556:secondary; D001918:Brachytherapy / Q000379:methods; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy*; D011868:Radioisotopes; D011883:Radium; D019233:Retreatment; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D011868:Radioisotopes; D011883:Radium